CD4+CD56+ lineage negative hematopoietic neoplasm: So called blastic NK cell lymphoma

被引:13
|
作者
Kim, Y
Kang, MS
Kim, CW
Sung, RY
Ko, YH
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea
[2] Soonchunhyang Univ, Cheonan Hosp, Dept Pathol, Cheonan, South Korea
[3] Inje Univ, Pusan, South Korea
[4] Busan Paik Hosp, Pusan, South Korea
[5] Chungbuk Univ, Coll Med, Cheongju, South Korea
关键词
killer cells; natural; lymphoma; blastic NK cell; DNTTIP1; protein; human; receptor-CD3; complex; antigen; T-cell;
D O I
10.3346/jkms.2005.20.2.319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Blastic natural killer (NK) cell lymphoma is a rare neoplasm characterized by blastoid tumor cells expressing CD4 and GD56, with predominant skin involvement. Although this tumor has been regarded as a neoplasm related to NK cell, recent studies suggested that it is derived from plasmacytoid dendritic cells, but not from NK cell. Herein we report 4 cases of CD4+CD56+ lineage marker- blastic NK cell lymphomas with a review of literatures. The patients were 3 men and one woman. Three of them were young (17, 18, and 22 yr old). Three patients had skin lesions, at initial presentation in two patients and during the course of disease in other patient. Histologically, tumors consisted of monotonous medium to large blastoid cells showing no necrosis, angiocentric growth or epidermotrophism. All four tumors were CD4+ and CD56+. Three expressed CD68 antigen. Lineage specific markers for B- and T cell were negative. All tumors did not express myeloperoxiclase. T-cell receptor gene rearrangement, EBV, CD13 and CD33 were negative. In one patient, tumor cells arranged in Homer-Wright type pseudorosette and expressed terminal deoxynucleotidyl transferase (TdT). Despite the standard lymphoma chemotherapy, the tumors, except one lost during follow-up, progressed and relapsed. The patients died 8-60 months after diagnosis.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 50 条
  • [31] A CD56-immunoblastoid variant of blastic plasmacytoid dendritic cell neoplasm
    Aran, Brenna M.
    Duran, Juanita
    Whittemore, Darren
    Gru, Alejandro A.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2024, 51 (01) : 40 - 44
  • [32] Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behcet's disease
    Eksioglu-Demiralp, E
    Direskeneli, H
    Ergun, T
    Fresko, I
    Akoglu, T
    RHEUMATOLOGY INTERNATIONAL, 1999, 19 (1-2) : 23 - 26
  • [33] Primary cutaneous non-T non-B CD4+CD56+ lymphomas are not NK cell lymphomas.
    Bagot, M
    Bouloc, A
    Charue, D
    Wechsler, J
    Bensussan, A
    Boumsell, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (01) : 127 - 127
  • [34] Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease
    E. Eksioglu-Demiralp
    H. Direskeneli
    T. Ergun
    I. Fresko
    T. Akoglu
    Rheumatology International, 1999, 19 : 23 - 26
  • [35] A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman
    Chang, SE
    Choi, HJ
    Huh, J
    Choi, JH
    Sung, KJ
    Moon, KC
    Koh, JK
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2002, 24 (01) : 72 - 75
  • [36] CD123-NEGATIVE VARIANT OF CD4+/CD56+HEMATODERMIC NEOPLASM
    Desai, H.
    Malhotra, R.
    Uzieblo, A.
    Levin, E.
    Frank, M.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2009, 36 (01) : 175 - 176
  • [37] CD56-Negative Extranodal Nasal Type NK/T-Cell Lymphoma
    Miles, Rodney R.
    Afify, Zeinab
    Yaish, Hassan
    Perkins, Sherrie L.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (01) : 186 - 189
  • [38] Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma
    Waziri, Allen
    Killory, Brendan
    Ogden, Alfred T., III
    Canoll, Peter
    Anderson, Richard C. E.
    Kent, Sally C.
    Anderson, David E.
    Bruce, Jeffrey N.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (11): : 7673 - 7680
  • [39] CD4+/CD56+TdT+ haematodermic neoplasm (previously called blastic natural killer cell lymphoma) in a patient with chronic human T-cell leukaemia virus type 1 infection: a previously unreported association
    Gurgen, J.
    Hogan, D.
    Muller, K.
    Flowers, J.
    Sexton, W.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (06) : 1395 - 1397
  • [40] Clinicopathologic Characteristics and Outcome of CD4+/CD56+Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single Institutional Experience.
    Naghashpour, Mojdeh
    Yu, I-Ting
    Moscinski, Lynn C.
    Sokol, Lubomir
    Cualing, Hernani
    BLOOD, 2009, 114 (22) : 650 - 650